<DOC>
	<DOCNO>NCT00388180</DOCNO>
	<brief_summary>The investigational drug administer study activate protein call PPARs . Data scientific literature PPARs , well animal data early clinical data generate GSK drug , suggest activation PPARs may cause body increase use fatty acid energy , lead reduction body fat . There also data suggest role PPARs regulate lipid ( e.g. , cholesterol ) level inflammation . These activity PPARs explore clinical study .</brief_summary>
	<brief_title>An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Inclusion criterion : Body Mass Index range 27 43 kg/m2 Waist circumference &gt; 95cm Exclusion criterion : Clinically relevant abnormality screen ECG/holter , labs medical examination Use tobacco within 6 month study Regular strenuous exercise Use prescription nonprescription medication , include vitamin herbal/dietary supplement LDL &lt; 80mg/dL ; TG &lt; 100mg/dL &gt; 400mg/dL</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>cholesterol</keyword>
	<keyword>inflammation</keyword>
	<keyword>fat</keyword>
</DOC>